DarioHealth Historical Cash Flow
| DRIO Stock | USD 1.21 0.04 3.42% |
Analysis of DarioHealth Corp cash flow over time is an excellent tool to project DarioHealth Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 52 M or Other Cashflows From Financing Activities of 13.6 M as it is a great indicator of DarioHealth Corp ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining DarioHealth Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DarioHealth Corp is a good buy for the upcoming year.
DarioHealth |
About DarioHealth Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in DarioHealth balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which DarioHealth's non-liquid assets can be easily converted into cash.
DarioHealth Corp Cash Flow Chart
DarioHealth Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the DarioHealth Corp Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
DarioHealth Corp reported last year Sale Purchase Of Stock of (134,000). As of the 18th of April 2024, Change To Inventory is likely to grow to about 3 M, though Change In Cash is likely to grow to (11.8 M). Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by DarioHealth Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of DarioHealth Corp operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from DarioHealth Corp's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into DarioHealth Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.DarioHealth Corp reported last year Sale Purchase Of Stock of (134,000). As of the 18th of April 2024, Change To Inventory is likely to grow to about 3 M, though Change In Cash is likely to grow to (11.8 M).
| 2023 | 2024 (projected) | Net Borrowings | 21.4M | 19.0M | Issuance Of Capital Stock | 16.7M | 15.9M |
DarioHealth Corp cash flow statement Correlations
Click cells to compare fundamentals
DarioHealth Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
DarioHealth Corp cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 9.4M | 8.2M | 7.2M | 13.5M | (12.4M) | (11.8M) | |
| Stock Based Compensation | 2.3M | 11.1M | 25.0M | 17.0M | 19.7M | 20.7M | |
| Free Cash Flow | (15.8M) | (17.9M) | (50.7M) | (48.4M) | (31.0M) | (29.4M) | |
| Change In Working Capital | (429K) | 417K | (2.6M) | (10.9M) | 4.4M | 4.6M | |
| Begin Period Cash Flow | 11.1M | 20.5M | 28.7M | 35.9M | 49.5M | 52.0M | |
| Other Cashflows From Financing Activities | 25.2M | 27.5M | 889K | 71.4M | 16.6M | 13.6M | |
| Depreciation | 183K | 190K | 3.3M | 4.7M | 5.2M | 5.5M | |
| Other Non Cash Items | 4.7M | 12.7M | 637K | 3.6M | 1.1M | 1.0M | |
| Capital Expenditures | 98K | 118K | 261K | 573K | 584K | 354.4K | |
| Total Cash From Operating Activities | (15.7M) | (17.7M) | (50.4M) | (47.8M) | (30.4M) | (28.9M) | |
| Net Income | (17.7M) | (29.4M) | (76.8M) | (62.2M) | (54.9M) | (52.1M) | |
| Total Cash From Financing Activities | 25.2M | 27.5M | 65.8M | 61.9M | 18.3M | 24.6M | |
| End Period Cash Flow | 20.5M | 28.7M | 35.9M | 49.5M | 37.1M | 38.9M | |
| Sale Purchase Of Stock | (1K) | 25.2M | 27.5M | 65.8M | (134K) | 0.0 | |
| Change To Inventory | (37K) | (879K) | (2.2M) | (1.7M) | 2.9M | 3.0M | |
| Investments | (113K) | (1.5M) | (400K) | (573K) | (523K) | (549.2K) | |
| Cash And Cash Equivalents Changes | 9.4M | 8.2M | 7.2M | 13.5M | 15.6M | 16.3M | |
| Cash Flows Other Operating | 659K | (1.1M) | 933K | 36K | 32.4K | 30.8K | |
| Change To Account Receivables | (504K) | 548K | (351K) | (5.1M) | 2.8M | 3.0M | |
| Change To Operating Activities | 543K | (77K) | (1.4M) | (1.9M) | (1.7M) | (1.6M) | |
| Other Cashflows From Investing Activities | (15K) | (4K) | (7.5M) | (131K) | (117.9K) | (123.8K) | |
| Change To Netincome | 2.3M | 11.1M | 25.0M | 17.0M | 19.5M | 20.5M | |
| Change To Liabilities | (547K) | 1.9M | (288K) | (4.6M) | (4.1M) | (3.9M) | |
| Change Receivables | (504K) | 548K | (351K) | (5.1M) | (4.6M) | (4.4M) | |
| Issuance Of Capital Stock | 25.2M | 27.5M | 64.9M | 38.3M | 16.7M | 15.9M |
Pair Trading with DarioHealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving together with DarioHealth Stock
| 0.77 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against DarioHealth Stock
| 0.78 | GCTK | GlucoTrack | PairCorr |
| 0.59 | ELMD | Electromed | PairCorr |
| 0.55 | WST | West Pharmaceutical Earnings Call This Week | PairCorr |
| 0.53 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.53 | RMD | ResMed Inc Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for DarioHealth Stock analysis
When running DarioHealth Corp's price analysis, check to measure DarioHealth Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DarioHealth Corp is operating at the current time. Most of DarioHealth Corp's value examination focuses on studying past and present price action to predict the probability of DarioHealth Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DarioHealth Corp's price. Additionally, you may evaluate how the addition of DarioHealth Corp to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is DarioHealth Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.93) | Revenue Per Share 0.717 | Quarterly Revenue Growth (0.47) | Return On Assets (0.33) | Return On Equity (0.86) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.